Granules India's subsidiary, Granules Pharmaceuticals Inc, has been granted approval by the US health regulator for a generic Glycopyrrolate oral solution meant for pediatric patients with neurological conditions linked to drooling. Granules India...
Gilead Sciences has collaborated with PANTHERx Rare to provide LIVDELZI, a medication aimed at adults suffering from primary biliary cholangitis (PBC). The goal of the partnership is to offer patients the specific peroxisome proliferator-activated...
Vimgreen Pharmaceuticals, a research-based pharmaceutical company specializing in adenosine signaling modulation, shared that they have finished enrolling participants in a phase 2 clinical trial for VG081821AC, a new drug for early-to-mid stage...
In July, the domestic pharmaceutical retail market witnessed a remarkable 11 percent increase. This phenomenon can be referred to as the flu impact. Increased sales of anti-infectives and pain relief suggest a rise in cases of flu and other viral...
Orchid Pharma announced a consolidated net profit of Rs. In the first quarter ending on June 30, 2024, the revenue increased by over three times to Rs 32.95 crore, exceeding the Rs 9.4 crore recorded in the same quarter of the previous fiscal...
Biosyngen, a company focused on immuno-oncology, stated that its EBV-specific CAR-T cell therapy, BRG01, has received approval from the US Food and Drug Administration (FDA) to advance into a crucial phase II clinical trial. This is the initial...
On the occasion of India's 78th Independence Day, it is a time to look back on the incredible progress and successes achieved, especially in the pharmaceutical sector. Over the years, India has become a leading player in pharmaceutical innovation...
AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been conditionally approved in China for treating adult patients with advanced HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma after two or more prior...
Mabwell, a forward-thinking biopharmaceutical company with a complete industry chain, revealed that its new Nectin-4 targeting ADC has received Breakthrough Therapy Designation (BTD) from the Center for Drug Evaluation (CDE) of the National...
The US FDA has approved Enzeevu (aflibercept-abzv) 2 mg vial kit and pre-filled syringe for intravitreal injection by Sandoz, the leading company in generic and biosimilar medicines worldwide. Enzeevu is recommended for enhancing and preserving...
, CDSCO.jpg)
.jpg)